Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris
- 26 Downloads
The hemodynamic consequences of blockade at both beta-adrenoceptors and slow calcium channels is of therapeutic importance for patients with angina pectoris. The hemodynamic interaction of a new cardioselective beta blocker, celiprolol, and nifedipine was examined in an acute hemodynamic study using three prospectively matched groups with angiographically confirmed coronary artery disease (n = 10/group). Patients were randomly allocated to intravenous celiprolol (8 mg), sublingual nifedipine (20 mg), or their combination. Rest and exercise (supine bicycle) hemodynamics were determined before and following each therapy. At rest, celiprolol did not alter pumping function; nifedipine reduced diastolic blood pressure and systemic vascular resistance index (SVRI), with a small increase in heart rate. Combination therapy reduced systemic arterial pressure and SVRI; heart rate and cardiac stroke volume index increased. During exercise celiprolol tended to reduce heart rate and cardiac index; nifedipine reduced exercise SVR and cardiac stroke work indices. Combination therapy reduced all components of blood pressure; cardiac stroke work and SVR indices fell. These hemodynamic data suggest that beta blockade with celiprolol may result in a slight depression of cardiac pumping during exercise; however, such effects are offset by the vasodilating actions of nifedipine (reflex sympathetic action offsetting cardiodepression). Thus the acute hemodynamic effects of this combination were seemingly safe in these patients; the longer term effects during maintained therapy should be further assessed.
Key Wordsceliprolol nifedipine interaction between drugs angina
Unable to display preview. Download preview PDF.
- 4.Prichard BNC, Aellig WH, Richardson GA. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris; the effect on heart rate and the electrocardiogram.Postgrad Med J 1970;46:77–83.Google Scholar
- 6.Reale A, Nigri A, Gioffre PA, Motolese M. Acute influence of different beta-blocking drugs upon left heart haemodynamics at rest and during exercise in patients with coronary heart disease.Eur Heart J 1981;2:101–109.Google Scholar
- 9.Pittner H. Haemodynamic actions of celiprolol, a cardioselective beta-receptor blocker.Arzneimittelforsch 1983, 33(I):13–25.Google Scholar
- 11.Brodde OE, Daul A, Bock KD. The intrinsic sympathomimetic activity (ISA) of beta-adrenoreceptor (R) antagonists is not beta-R subtype selective.Naunyn-Schmiedebergs Arch Pharmac 1985;329:R 81.Google Scholar
- 12.Wolf PS, Smith RD, Khandwala A, et al. Celiprolol— pharmacological profile of an unconventional beta-blocker.Br J Clin Pract 1985;39(Suppl. 40):5–11.Google Scholar
- 13.Pittner H. Intrinsic sympathomimetic activity and its special features as exemplified by the beta-1-adrenoceptor blocker celiprolol.Wien Klin Wschr 1985;97:3–21.Google Scholar
- 25.Verma SP, Nelson GIC, Jackson N, et al. Haemodynamic variability at rest and following repetitive upright dynamic exercise in coronary heart disease (abstract)Clin Sci 1984;66:52P.Google Scholar
- 26.Dixon WJ, Brown MB, eds.Biomedical computer programs ‘P’ series. Berkeley: University of California Press, 1979: 540.Google Scholar
- 27.Winer B J.Statistical principles in experimental design, 2nd ed. New York: McGraw-Hill, 1977:197–200.Google Scholar
- 34.Brodde OE, Schemuth R, Binkman M, et al. Betaadrenoceptor antagonists (non-selective as well as beta1 selective) with partial agonist activity decrease beta2 adrenoceptor density in human lymphocytes. Evidence for a beta2-agonist component of the partial agonist activity.Naunyn-Schmiedeberg’s Arch Pharmacol 1986;333:130–138.CrossRefGoogle Scholar
- 36.Tham TCK, Riddell JG, Shanks RG. The effect of increasing doses of celiprolol on sleeping heart rate and quality of sleep in man.Clin Pharmacol Ther, 1991;49:187.Google Scholar